In today’s health headlines, how did the COVID-19 pandemic impact Americans’ drinking habits? Plus, researchers claim a new ...

BioNTech said that BNT327 has the "potential to replace current checkpoint inhibitor standard of care treatments for solid ...

Taiwan regulatory approval for the trial expected in Q1 2025Remains committed to a capital-efficient business strategySAN DIEGO, CA / ACCESSWIRE / November 13, 2024 / Ainos, Inc.

BioNTech will make $800mn in upfront payments to Biotheus, a drugmaker based in Guangdong province, with milestone payments of up to $150mn. Uğur Şahin, chief executive of BioNTech, said the company ...

The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...

Discover groundbreaking research from Emory University that has revealed that autoantibodies found in the nasal cavity may ...

Suicide remains a pressing public health concern. An estimated 703,000 people die by suicide each year worldwide, according to The World Health Organization. In 2022, there were 49,449 suicides in the ...

However, in the era of post COVID-19 consumer trends, these pharmacies must be able ... BioVeda China Fund, Oncology ...

In this interview, Tong Huo discusses the current landscape of CAR-T therapies and the future of CAR-T, including ...

In July 2024, Checkpoint announced that the FDA accepted for review the resubmission of its BLA for cosibelimab as a complete response to the complete response letter (“CRL”) issued in December 2023 ...

With a market cap of $18 billion, Moderna is at the forefront of innovative healthcare solutions, pioneering treatments for ...